Difference between revisions of "Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5 (Q9903)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Fujiwara Y, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 1715-1723, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1111/cas.14003 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 30891877 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2019
| ||||||||||||||
| Property / Publication Date: 2019 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cancer Sci. | ||||||||||||||
| Property / Published In Name String: Cancer Sci. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 110 | ||||||||||||||
| Property / Volume: 110 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English) | ||||||||||||||
| Property / title: Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 1715-1723 | ||||||||||||||
| Property / Page(s): 1715-1723 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fujiwara Y
0 references
2019
0 references
Cancer Sci.
0 references
110
0 references
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors (English)
0 references
1715-1723
0 references
